Cost-effectiveness of public-health policy options in the presence of pretreatment NNRTI drug resistance in sub-Saharan Africa: a modelling study

Autor: Phillips, Andrew N, Cambiano, Valentina, Nakagawa, Fumiyo, Revill, Paul, Jordan, Michael R, Hallett, Timothy B, Doherty, Meg, De Luca, Andrea, Lundgren, Jens D, Mhangara, Mutsa, Apollo, Tsitsi, Mellors, John, Nichols, Brooke, Parikh, Urvi, Pillay, Deenan, Rinke de Wit, Tobias, Sigaloff, Kim, Havlir, Diane, Kuritzkes, Daniel R, Pozniak, Anton, van de Vijver, David, Vitoria, Marco, Wainberg, Mark A, Raizes, Elliot, Bertagnolio, Silvia

Publikováno v: In The Lancet HIV March 2018 5(3):e146-e154

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Pre-treatment drug resistance among patients initiating antiretroviral therapy (ART) in Zimbabwe: 2008-2010.

Autor: Mungati, More^1,2 mungatim@yahoo.com, Mhangara, Mutsa¹, Gonese, Elizabeth³, Mugurungi, Owen¹, Dzangare, Janet¹, Ngwende, Stella⁴, Musasa, Patience⁴, Wellington, Maureen⁵, Shambira, Gerald², Apollo, Tsitsilina¹, Chunfu Yang⁶, DeVos, Joshua⁶, Sabatier, Jennifer⁶, Kilmarx, Peter³, Chakanyuka-Musanhu, Christine⁷, Mufuta Tshimanga²

Publikováno v: BMC Research Notes. 6/10/2016, Vol. 9, p1-7. 7p. 4 Charts, 2 Graphs.

Cost-effectiveness of public-health policy options in the presence of pretreatment NNRTI drug resistance in sub-Saharan Africa: a modelling study

Autor: Phillips, Andrew N, Cambiano, Valentina, Nakagawa, Fumiyo, Revill, Paul, Jordan, Michael R, Hallett, Timothy B, Doherty, Meg, De Luca, Andrea, Lundgren, Jens D, Mhangara, Mutsa, Apollo, Tsitsi, Mellors, John, Nichols, Brooke, Parikh, Urvi, Pillay, Deenan, Rinke de Wit, Tobias, Sigaloff, Kim, Havlir, Diane, Kuritzkes, Daniel R, Pozniak, Anton, van de Vijver, David, Vitoria, Marco, Wainberg, Mark A, Raizes, Elliot, Bertagnolio, Silvia

Publikováno v: E154
E146
LANCET HIV, 5(3), E146-E154. Elsevier Ltd.
Phillips, A N, Cambiano, V, Nakagawa, F, Revill, P, Jordan, M R, Hallett, T B, Doherty, M, De Luca, A, Lundgren, J D, Mhangara, M, Apollo, T, Mellors, J, Nichols, B, Parikh, U, Pillay, D, Rinke de Wit, T, Sigaloff, K, Havlir, D, Kuritzkes, D R, Pozniak, A, van de Vijver, D, Vitoria, M, Wainberg, M A, Raizes, E, Bertagnolio, S & Working Group on Modelling Potential Responses to High Levels of Pre-ART Drug Resistance in Sub-Saharan Africa 2018, ' Cost-effectiveness of public-health policy options in the presence of pretreatment NNRTI drug resistance in sub-Saharan Africa : a modelling study ', The Lancet HIV, vol. 5, no. 3, pp. e146-e154 . https://doi.org/10.1016/S2352-3018(17)30190-X

BACKGROUND: There is concern over increasing prevalence of non-nucleoside reverse-transcriptase inhibitor (NNRTI) resistance in people initiating antiretroviral therapy (ART) in low-income and middle-income countries. We assessed the effectiveness an

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::540900608daafe3220e1873f711e31db
http://hdl.handle.net/10044/1/60391

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.